Bellver S P, Beermann D H, Bell A W, Van Tassell C P, Hogue D E, McLaughlin C L
Department of Animal Science, Cornell University, Ithaca, NY 14853, USA.
Domest Anim Endocrinol. 1995 Apr;12(2):143-56. doi: 10.1016/0739-7240(94)00016-t.
The purpose of this study was to determine the effects of exogenous recombinant bovine somatotropin (bST) treatment on whole-body glycemic responsiveness and sensitivity to exogenous insulin in preruminant and ruminant lambs. Twelve milk-fed (MF) and 12 ruminating (RUM) wether lambs weighing 20 +/- 0.6 kg were assigned to one of four treatment groups: MF control, MF plus bST, RUM control, and RUM plus bST. Lambs received a daily subcutaneous injection of 160 micrograms of sometribove (recombinant methionyl bST) bST/kg live weight or the equivalent volume of sterile water (control) for 10 d. The MF lambs had higher plasma insulin and nonessential fatty acids and lower acetate concentrations than RUM lambs (all P < 0.05). Plasma insulin-like growth factor concentrations were similar in both. The administration of bST raised plasma insulin-like growth factor-1 (P < 0.001) and insulin (P < 0.05) in MF and RUM lambs, but with greater effect in MF lambs (P < 0.01 and P < 0.1, respectively). Six successive dose-incremented insulin challenges (50, 100, 200, 300, 500, and 700 mU/kg body weight) were performed two per day on Days 8, 9, and 10 of treatment. Dose-response curves for absolute decline in glucose concentration from preinjection baseline to nadir were used to characterize whole-body responsiveness and sensitivity (ED50) to insulin. Somatotropin treatment increased insulin ED50 values 64 and 70% (P < 0.07) in RUM and MF lambs, respectively, suggesting that sensitivity to insulin was reduced. Insulin ED50 values were 40% higher in MF than in RUM lambs (P < 0.05). Insulin clearance rates increased with each dose increment to 300 mU/kg body weight (P = 0.001) and were 50% lower in bST-treated MF lambs than in all other treatment groups (P < 0.05). Results suggest that somatotropin modulates the insulin control of glucose homeostasis similarly in preruminant and ruminant lambs by decreasing sensitivity but not maximum responsiveness.
本研究的目的是确定外源性重组牛生长激素(bST)处理对反刍前和反刍期羔羊全身血糖反应性及对外源性胰岛素敏感性的影响。将12只哺乳(MF)和12只反刍(RUM)的去势羔羊(体重20±0.6 kg)分配到四个处理组之一:MF对照组、MF加bST组、RUM对照组和RUM加bST组。羔羊每天皮下注射160微克的sometribove(重组甲硫氨酰bST)bST/千克活体重或等量的无菌水(对照组),持续10天。MF羔羊的血浆胰岛素和非必需脂肪酸水平高于RUM羔羊,乙酸盐浓度低于RUM羔羊(所有P<0.05)。两组的血浆胰岛素样生长因子浓度相似。bST的施用提高了MF和RUM羔羊的血浆胰岛素样生长因子-1(P<0.001)和胰岛素(P<0.05)水平,但对MF羔羊的影响更大(分别为P<0.01和P<0.1)。在处理的第8、9和10天,每天进行两次连续的剂量递增胰岛素挑战(50、100、200、300、500和700 mU/千克体重)。从注射前基线到最低点的葡萄糖浓度绝对下降的剂量反应曲线用于表征全身对胰岛素的反应性和敏感性(ED50)。生长激素处理分别使RUM和MF羔羊的胰岛素ED50值增加了64%和70%(P<0.07),表明对胰岛素的敏感性降低。MF羔羊的胰岛素ED50值比RUM羔羊高40%(P<0.05)。胰岛素清除率随着剂量增加到300 mU/千克体重而增加(P = 0.001),bST处理的MF羔羊的胰岛素清除率比所有其他处理组低50%(P<0.05)。结果表明,生长激素通过降低敏感性而非最大反应性,以类似方式调节反刍前和反刍期羔羊葡萄糖稳态的胰岛素控制。